• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p40/LAIR-1调节粒细胞-单核细胞集落刺激因子诱导的外周血前体细胞向树突状细胞的分化。

p40/LAIR-1 regulates the differentiation of peripheral blood precursors to dendritic cells induced by granulocyte-monocyte colony-stimulating factor.

作者信息

Poggi A, Tomasello E, Ferrero E, Zocchi M R, Moretta L

机构信息

Laboratorio di Immunopatologia, Istituto Nazionale per la Ricerca sul Cancro e Centro di Biotecnologie Avanzate CBA-IST, Genova, Italy.

出版信息

Eur J Immunol. 1998 Jul;28(7):2086-91. doi: 10.1002/(SICI)1521-4141(199807)28:07<2086::AID-IMMU2086>3.0.CO;2-T.

DOI:10.1002/(SICI)1521-4141(199807)28:07<2086::AID-IMMU2086>3.0.CO;2-T
PMID:9692876
Abstract

p40/LAIR-1, a member of the immunoglobulin superfamily, is a surface molecule broadly distributed among leukocytes which has been shown to down-regulate T and NK cell activation. In this study, we show that p40/LAIR-1 is highly expressed in CD14+ peripheral blood mononuclear cells (PBMC). When cultured in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) for 10-14 days, CD14+ cells acquired morphologic and phenotypic features (i.e. loss of CD14 and expression of CD80bright and CD86bright) typical of dendritic cells (DC) and lost the expression of p40/LAIR-1. Engagement of p40/LAIR-1 (but not of CD58) by specific monoclonal antibodies prevented CD14+ PBMC differentiation into DC; when cultured in the presence of GM- CSF upon p40/LAIR-1 cross-linking, the resulting cells were CD14+CD80(dull)CD86(dull) and displayed a macrophage-like morphology. We have recently demonstrated that peripheral blood CD14+ cells co-expressing the CD34 progenitor marker represent the circulating precursors of CD83+ DC. Herein we show that cross-linking of p40/LAIR-1 prevented the maturation of CD14+CD34+ cells into CD83+ DC. This effect appears to be consequent to the impairment of GM-CSF receptor-mediated activation signaling. Indeed, triggering of GM-CSF receptors in both CD14+ and CD14+CD34+ cells led to increases in the intracellular free calcium concentrations which were inhibited by p40/LAIR-1 engagement. Taken together, these data suggest a possible regulating role played by p40/LAIR-1 in the process of differentiation from peripheral blood precursors into DC induced by GM-CSF.

摘要

p40/LAIR-1是免疫球蛋白超家族的成员,是一种广泛分布于白细胞中的表面分子,已被证明可下调T细胞和NK细胞的活化。在本研究中,我们发现p40/LAIR-1在CD14+外周血单核细胞(PBMC)中高表达。当在粒细胞-巨噬细胞集落刺激因子(GM-CSF)存在下培养10-14天时,CD14+细胞获得了树突状细胞(DC)典型的形态和表型特征(即CD14丢失以及CD80bright和CD86bright表达),并失去了p40/LAIR-1的表达。特异性单克隆抗体与p40/LAIR-1(而非CD58)结合可阻止CD14+ PBMC分化为DC;当在p40/LAIR-1交联后在GM-CSF存在下培养时,产生的细胞为CD14+CD80(dull)CD86(dull),并呈现巨噬细胞样形态。我们最近证明,共表达CD34祖细胞标志物的外周血CD14+细胞代表CD83+ DC的循环前体。在此我们表明,p40/LAIR-1交联可阻止CD14+CD34+细胞成熟为CD83+ DC。这种效应似乎是由于GM-CSF受体介导的活化信号受损所致。事实上,在CD14+和CD14+CD34+细胞中触发GM-CSF受体会导致细胞内游离钙浓度升高,而p40/LAIR-1结合可抑制这种升高。综上所述,这些数据表明p40/LAIR-1在GM-CSF诱导的外周血前体向DC分化过程中可能发挥调节作用。

相似文献

1
p40/LAIR-1 regulates the differentiation of peripheral blood precursors to dendritic cells induced by granulocyte-monocyte colony-stimulating factor.p40/LAIR-1调节粒细胞-单核细胞集落刺激因子诱导的外周血前体细胞向树突状细胞的分化。
Eur J Immunol. 1998 Jul;28(7):2086-91. doi: 10.1002/(SICI)1521-4141(199807)28:07<2086::AID-IMMU2086>3.0.CO;2-T.
2
Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4.人CD14 +白细胞在GM-CSF和IL-4中培养时可获得抗原呈递树突状细胞的表型和功能。
J Leukoc Biol. 1996 Feb;59(2):208-18. doi: 10.1002/jlb.59.2.208.
3
Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions.粒细胞巨噬细胞集落刺激因子和催乳素在无血清条件下对血液单核细胞来源树突状细胞成熟的单独及联合作用
Immunology. 2000 May;100(1):29-36. doi: 10.1046/j.1365-2567.2000.00996.x.
4
Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.通过与粒细胞巨噬细胞集落刺激因子、白细胞介素-4和肿瘤坏死因子-α共同培养,从脐血贴壁细胞生成树突状细胞。
J Hematother Stem Cell Res. 2000 Aug;9(4):453-64. doi: 10.1089/152581600419116.
5
Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1/PKB alpha activation in primary acute myeloid leukemia cells.
Eur J Immunol. 2001 Dec;31(12):3667-75. doi: 10.1002/1521-4141(200112)31:12<3667::aid-immu3667>3.0.co;2-g.
6
Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.干细胞因子增强肿瘤坏死因子-粒细胞巨噬细胞集落刺激因子介导的树突状细胞造血作用。
Stem Cells. 1995 Mar;13(2):186-97. doi: 10.1002/stem.5530130210.
7
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.来自人脐带血的CD34+造血祖细胞在粒细胞巨噬细胞集落刺激因子(GM-CSF)和肿瘤坏死因子α(TNFα)的作用下,沿着两条独立的树突状细胞途径分化。
J Exp Med. 1996 Aug 1;184(2):695-706. doi: 10.1084/jem.184.2.695.
8
Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.从脐带血CD34 +祖细胞分化而来的CD1a +树突状细胞前体对细胞凋亡具有特殊易感性。
Stem Cells. 1998;16(3):218-28. doi: 10.1002/stem.160218.
9
Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.肿瘤细胞对CD34(+)祖细胞分化为树突状细胞的抑制作用:白细胞介素-6和巨噬细胞集落刺激因子的作用
Blood. 1998 Dec 15;92(12):4778-91.
10
Expression and function of NKRP1A molecule on human monocytes and dendritic cells.NKRP1A分子在人单核细胞和树突状细胞上的表达及功能
Eur J Immunol. 1997 Nov;27(11):2965-70. doi: 10.1002/eji.1830271132.

引用本文的文献

1
The Role of LAIR1 as a Regulatory Receptor of Antitumor Immune Cell Responses and Tumor Cell Growth and Expansion.LAIR1作为抗肿瘤免疫细胞反应以及肿瘤细胞生长与增殖的调节性受体的作用。
Biomolecules. 2025 Jun 13;15(6):866. doi: 10.3390/biom15060866.
2
LAIR1 prevents excess inflammatory tissue damage in skin infection and Cutaneous T-cell Lymphoma.LAIR1可预防皮肤感染和皮肤T细胞淋巴瘤中过度的炎症组织损伤。
bioRxiv. 2024 Jun 16:2024.06.13.598864. doi: 10.1101/2024.06.13.598864.
3
Expression analysis of Carassius auratus-leukocyte-immune-type receptors (CaLITRs) during goldfish kidney macrophage development and in activated kidney leukocyte cultures.
金鱼肾巨噬细胞发育过程中及活化的肾白细胞培养物中鲫鱼白细胞免疫型受体(CaLITRs)的表达分析
Immunogenetics. 2023 Apr;75(2):171-189. doi: 10.1007/s00251-023-01298-5. Epub 2023 Feb 18.
4
LAIR1, an ITIM-Containing Receptor Involved in Immune Disorders and in Hematological Neoplasms.LAIR1,一种包含 ITIM 的受体,与免疫紊乱和血液系统肿瘤有关。
Int J Mol Sci. 2022 Dec 17;23(24):16136. doi: 10.3390/ijms232416136.
5
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction.NC410 通过阻断人 LAIR-2 与胶原的相互作用进行癌症免疫治疗。
Elife. 2021 Jun 14;10:e62927. doi: 10.7554/eLife.62927.
6
Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1.基于阻断由免疫调节因子LAIR-1介导的免疫抑制的癌症免疫疗法。
Oncoimmunology. 2020 Apr 7;9(1):1740477. doi: 10.1080/2162402X.2020.1740477.
7
Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment.细胞外基质在肝脏疾病微环境中的免疫调节作用。
Front Immunol. 2020 Nov 11;11:574276. doi: 10.3389/fimmu.2020.574276. eCollection 2020.
8
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer.人类自然杀伤细胞中的抑制性受体和检查点及其在癌症免疫治疗中的意义。
Front Immunol. 2020 Sep 3;11:2156. doi: 10.3389/fimmu.2020.02156. eCollection 2020.
9
Leukocyte Associated Immunoglobulin Like Receptor 1 Regulation and Function on Monocytes and Dendritic Cells During Inflammation.白细胞相关免疫球蛋白样受体 1 在炎症期间对单核细胞和树突状细胞的调节和功能。
Front Immunol. 2020 Aug 19;11:1793. doi: 10.3389/fimmu.2020.01793. eCollection 2020.
10
LAIR-1 suppresses cell growth of ovarian cancer cell via the PI3K-AKT-mTOR pathway.LAIR-1 通过 PI3K-AKT-mTOR 通路抑制卵巢癌细胞的生长。
Aging (Albany NY). 2020 Sep 5;12(16):16142-16154. doi: 10.18632/aging.103589.